🏥 Care providers
In this section, you will find a list of our major customers in this segment.
- Hospital Universitario de Torrejón
- Hospital Ribera Molina
- Clinica de la Asunción
- Clinica Dermatológica IGDerma
- Hospital Puerta del Hierro
- Hospital Universitario San Roque
- Hospital Universitario Doctor Peset
- Hospital Universitario Cruces
- Centro residencial Sanitas Linares
- Centro residencial Sanitas Mas Camarena
- H. U. San Roque en Las Palmas de Gran Canaria
- Centro residencial Sanitas Alameda de Osuna
- Centro residencial Sanitas Mevefares
- Centro residencial Sanitas Altanova
- Centro residencial Sanitas Carabanchel
- Centro residencial Sanitas Colmenar Viejo
- Centro residencial Sanitas Cornella
- Centro residencial Sanitas Henares
- Centro residencial Sanitas Jardines de Sabatini
- Centro residencial Sanitas Las Rozas
- Centro residencial Sanitas Loramendi
- Centro residencial Sanitas Miramon
- Centro residencial Sanitas Tarragona
- Centro residencial Sanitas Valladolid
- Chirurgische Praxis am Dornbusch
- C.S.R. INVERSIONES SANITARIAS SUR, S.A.
- Hospital Universitario La Moraleja
- AREA DERMATOLOGICA IDERMA SL
- Hospital Universitario Puerta de Hierro
- Hospital Ribera Molina
- Centro de Salud Valle de la Oliva
- Centro de Salud San Juan de la Cruz
- Centro de Salud Sodupe
- Centro de Salud Balmaseda
- Centro de Salud Buruaga
- Centro de Salud Zurbaran
- Lychee Internet Hospital
- Società e Salute (Santagostino)
Summary
Here's a screenshot of our sales pipeline for this segment.
Ribera Salud
In the following videos (one in English, and one in Spanish), Dr Elena Sanchez-Largo explain how they are using Legit.Health at the Hospital de Torrejón, in Madrid. Hospital de Torrejón is one of the hospitals owned by Ribera Salud.
Spanish | English |
---|---|
SERMAS
SERMAS is the acronym for "Servicio Madrileñoo de Salud". SERMAS is using Legit.Health to help General Practitioners (GPs) increase the adequacy of referals. The study encompassed the collaboration of three medical institutions: Hospital Universitario Puerta de Hierro, alongside two primary care centers namely, Valle de la Oliva and San Juan de la Cruz. A total of 40 practitioners and 100 patients participated in this study. GPs incorporated Legit.Health as a supplementary resource whenever they encountered cases that lacked a significant level of diagnostic confidence before making a referral to a specialist.
By employing Legit.Health, they were able to augment their diagnostic capabilities by up to 13%. Notably, medical professionals acknowledged the effectiveness of Legit.Health in facilitating the diagnosis of skin cancer, a pivotal aspect of their clinical practice. For more comprehensive insights regarding the study, please check the clinical protocol:
In this image, you can see the Chief of Dermatology of the Hospital Puerta de Hierro, Dr. Gastón Roustan, next to several General Practitioners from two outpatient organisations, celebrating the results of the user of Legit.Health in Madrid. In this picture, you can also see representatives from Novartis, as well as Alfonso Medela and Gerardo Fernandez, our Head of Medical Data Science and our CTO.
Osakidetza
Osakidetza, the Basque Health Service, has been a collaborative partner since 2019 when we initiated our first clinical validation study. Our diagnostic support and triage capabilities garnered exceptionally positive outcomes, capturing the attention and interest of the head dermatologists Dr. Jesus Gardeazabal from Cruces and Dr. Rosa Izu from Basurto. Recognizing the value of our tool, they expressed a keen desire to implement it within their respective hospitals.
To further substantiate our initiative from a business perspective prior to a system-wide implementation, we have commenced a concise study of 6 months in 2023. Presently, we have already enrolled approximately 50 patients and are meticulously measuring the reduction in waiting lists and associated costs. These key metrics will provide valuable insights into the potential impact and advantages of incorporating our tool more extensively. For more information regarding the study, please check the clinical protocol:
Healthcare providers pain
For profit (private) care providers
For-profit care providers are diverse across Europe, but share some pains:
- Lack of specialists.
- Difficulty to provide care remotely with a degree of customer satisfaction equiparable to in-person consultation.
- High fragmentation regarding digital solutions.
This causes for-profit care providers to suffer frustrations:
- Patients wait up to 12 months to receive medical assistance
- Insurance companies are ambivalent about reimbursing remote consultations at the same value than in-person consultations.
- For-profit care providers are unable to cover the demand of the dermatology market. Their supply capacity does
Government (public) care providers
Government care providers in Europe are at a difficult position due to 3 factors:
- General practitioners and nurses have insufficient knowledge about skin diseases and wounds; and there is a lack of specialists.
- The incidence of skin disorders and wounds is high and is increasing.
- New treatments for severe conditions are very expensive.
Thus, care providers to suffer frustrations:
- Patients have to wait up to 1 year to receive medical assistance
- Doctors suffer burnout and dermatologists are increasingly switching to cosmetic medicine.
- It's difficult to monitor and supervise efficacy of treatments, which makes it difficult to bargain with pharmaceutical companies.
How Legit.Health is helping
For profit (private) care providers
For-profit care providers benefit from:
- The Diagnosis Support and the Automatic Severity Assessment
Assessment features empower non-specialists to provide a higher degree of care. This improves the
supply capacity, and thus reduces the waiting time for patients and increases the quantity of medical
acts they can invoice. - The Patient and Doctor App feature outputs HL7 FHIR®-compliant Diagnostic
Reports with all the required clinical information. By doing so, the output of the solution is equivalent to a report generated by a physician, which ensures that it will be reimbursed like a medical act, even when the physician did not intervene at all. - The solution covers 232 conditions (soon to be 323) and it is usable by multiple departments: primary care, dermatology and nursing.
Government (public) care providers
Government care providers benefit from:
- The Diagnosis Support and the Automatic Severity Assessment features empower non-specialists. This also reduces the workload of the specialists and automates the follow-up of chronic patients.
- The Smart Referral feature increases the adequacy of referrals. It scores pre-malignancy, malignancy, severity and outputs a referral index, not only for skin cancer, but for hundreds of conditions.
- The Automatic Severity Assessment feature evaluates the effectiveness of treatments. This empowers care providers to supervise the drugs' performance and trigger compensation clauses when the treatment falls short.
- The Therapy Success feature predicts how a patient will respond to treatment in a predictive way. This increases the adequacy of prescriptions and dosage. In turn, saves costs and improves safety.
- The Patient and Doctor App feature keeps patients adhered to the treatment, increasing efficacy and reducing prescription costs.